Due to the scarcity of ACh in AD, the use of cholinesterase inhibitors is among the useful therapeutic options to maintain the accumulation of neurotransmitter for a long time at the synapse (Bachman et al., 1992). The gene discussed is BCHE; the disease is Alzheimer disease.